TIFFANY TERRELL: Open Payments
NPI 1548661440 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,537 in 192 payments from 21 companies in 2025. Trend: 2023 $21,759 · 2024 $16,410 · 2025 $9,537
Food & beverage: $5,066Consulting: $3,765Travel & lodging: $706
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 23 | $1,932 |
| Mallinckrodt Hospital Products Inc. | 10 | $1,437 |
| Eli Lilly and Company | 1 | $1,200 |
| E.R. Squibb & Sons, L.L.C. | 10 | $1,054 |
| Amgen Inc. | 48 | $938 |
| ABBVIE INC. | 33 | $794 |
| UCB, Inc. | 20 | $562 |
| Janssen Biotech, Inc. | 9 | $298 |
| GENZYME CORPORATION | 2 | $295 |
| Lilly USA, LLC | 8 | $239 |
Products named: TALTZ, ACTHAR, RINVOQ, Bimzelx, COSENTYX, OTEZLA, TREMFYA, KEVZARA.
Industry payments across LA — which companies pay providers there.
